Insider Trading Alert - Sapient Corporation And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 1, 2013, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $4.49 to $3,242,400,000.00.

Highlighted Stocks Traded by Insiders:

Sapient Corporation (SAPE) - FREE Research Report

Moore J Stuart who is Director at Sapient Corporation sold 100,000 shares at $15.84 on Oct. 1, 2013. Following this transaction, the Director owned 6.8 million shares meaning that the stake was reduced by 1.46% with the 100,000 share transaction.

The shares most recently traded at $15.70, down $0.14, or 0.89% since the insider transaction. Historical insider transactions for Sapient Corporation go as follows:

  • 4-Week # shares sold: 415,800
  • 12-Week # shares sold: 588,800
  • 24-Week # shares sold: 588,800

The average volume for Sapient Corporation has been 724,800 shares per day over the past 30 days. Sapient Corporation has a market cap of $2.2 billion and is part of the technology sector and computer software & services industry. Shares are up 50.76% year to date as of the close of trading on Tuesday.

Sapient Corporation provides various services that enable clients to leverage marketing and technology to transform their businesses in the United States and internationally. It operates in three segments: SapientNitro, Sapient Global Markets, and Sapient Government Services. The company has a P/E ratio of 31.2. Currently there is 1 analyst that rates Sapient Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAPE - FREE

TheStreet Quant Ratings rates Sapient Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Sapient Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Altera (ALTR) - FREE Research Report

Howe Bradley Steven who is Sr VP, Research & Development at Altera sold 5,985 shares at $30.75 on Oct. 1, 2013. Following this transaction, the Sr VP, Research & Development owned 8,750 shares meaning that the stake was reduced by 40.62% with the 5,985 share transaction.

The shares most recently traded at $36.77, up $6.02, or 16.38% since the insider transaction. Historical insider transactions for Altera go as follows:

  • 4-Week # shares sold: 8,381
  • 12-Week # shares sold: 66,892
  • 24-Week # shares sold: 86,204

The average volume for Altera has been 3.0 million shares per day over the past 30 days. Altera has a market cap of $11.9 billion and is part of the technology sector and electronics industry. Shares are up 8.64% year to date as of the close of trading on Tuesday.

Altera Corporation, a semiconductor company, designs, manufactures, and markets programmable logic devices (PLD), HardCopy application-specific integrated circuit (ASIC) devices, pre-defined design building blocks, and proprietary development software. The stock currently has a dividend yield of 1.61%. The company has a P/E ratio of 23.9. Currently there are 10 analysts that rate Altera a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALTR - FREE

TheStreet Quant Ratings rates Altera as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Altera Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Medicines (MDCO) - FREE Research Report

Antinori Paul Michael who is Sr. VP & General Counsel at Medicines sold 894 shares at $33.16 on Oct. 1, 2013. Following this transaction, the Sr. VP & General Counsel owned 51,012 shares meaning that the stake was reduced by 1.72% with the 894 share transaction.

The shares most recently traded at $34.01, up $0.85, or 2.5% since the insider transaction. Historical insider transactions for Medicines go as follows:

  • 4-Week # shares sold: 23,500
  • 12-Week # shares sold: 38,500
  • 24-Week # shares sold: 56,209

The average volume for Medicines has been 945,200 shares per day over the past 30 days. Medicines has a market cap of $1.8 billion and is part of the health care sector and drugs industry. Shares are up 33.58% year to date as of the close of trading on Tuesday.

The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company has a P/E ratio of 48.5. Currently there are 5 analysts that rate Medicines a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDCO - FREE

TheStreet Quant Ratings rates Medicines as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Medicines Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

MarkWest Energy Partners (MWE) - FREE Research Report

Nickerson Randy S who is EVP, Chief Commercial Officer at MarkWest Energy Partners sold 1,500 shares at $72.22 on Oct. 1, 2013. Following this transaction, the EVP, Chief Commercial Officer owned 229,619 shares meaning that the stake was reduced by 0.65% with the 1,500 share transaction.

Bromley C Corwin who is EVP, General Counsel at MarkWest Energy Partners sold 5,000 shares at $73.01 on Oct. 1, 2013. Following this transaction, the EVP, General Counsel owned 75,276 shares meaning that the stake was reduced by 6.23% with the 5,000 share transaction.

The shares most recently traded at $73.18, up $0.17, or 0.23% since the insider transaction. Historical insider transactions for MarkWest Energy Partners go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 18,000
  • 24-Week # shares sold: 38,800

The average volume for MarkWest Energy Partners has been 779,300 shares per day over the past 30 days. MarkWest Energy Partners has a market cap of $10.1 billion and is part of the basic materials sector and energy industry. Shares are up 38.44% year to date as of the close of trading on Tuesday.

Markwest Energy Partners, L.P., together with its subsidiaries, engages in the gathering, processing, and transportation of natural gas the United States. The stock currently has a dividend yield of 4.76%. The company has a P/E ratio of 147.1. Currently there are 10 analysts that rate MarkWest Energy Partners a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MWE - FREE

TheStreet Quant Ratings rates MarkWest Energy Partners as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full MarkWest Energy Partners Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Casey's General Stores (CASY) - FREE Research Report

Haynie Kenneth H who is Director at Casey's General Stores sold 4,000 shares at $73.48 on Oct. 1, 2013. Following this transaction, the Director owned 26,162 shares meaning that the stake was reduced by 13.26% with the 4,000 share transaction.

The shares most recently traded at $72.75, down $0.73, or 1% since the insider transaction.

The average volume for Casey's General Stores has been 194,800 shares per day over the past 30 days. Casey's General Stores has a market cap of $2.8 billion and is part of the services sector and retail industry. Shares are up 37.82% year to date as of the close of trading on Tuesday.

Casey's General Stores, Inc., together with its subsidiaries, operates convenience stores under the Casey's General Store name in 14 Midwestern states, primarily Iowa, Missouri, and Illinois. The stock currently has a dividend yield of 0.98%. The company has a P/E ratio of 22.3. Currently there are 2 analysts that rate Casey's General Stores a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CASY - FREE

TheStreet Quant Ratings rates Casey's General Stores as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Casey's General Stores Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Alphabet Shares Gain as Investors Shrug Off Q1 Google Spending Spree

Alphabet Shares Gain as Investors Shrug Off Q1 Google Spending Spree

SAP Shares Leap After Cloud Business Prompts Full-Year Profit Guidance Hike

SAP Shares Leap After Cloud Business Prompts Full-Year Profit Guidance Hike

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength